Swedbank’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-60,200
Closed -$2.1M 760
2022
Q2
$2.1M Buy
60,200
+40,000
+198% +$1.42M ﹤0.01% 595
2022
Q1
$997K Buy
20,200
+5,000
+33% +$277K ﹤0.01% 680
2021
Q4
$1.19M Sell
15,200
-30
-0.2% -$3.08K ﹤0.01% 680
2021
Q3
$1.63M Sell
15,230
-4,985
-25% -$571K ﹤0.01% 662
2021
Q2
$2.69M Sell
20,215
-77,354
-79% -$8.99M 0.01% 624
2021
Q1
$12.1M Buy
+97,569
New +$14.8M 0.03% 424

Other funds holding TWST

Swedbank's TWST Position: Q3 2022 in Review

Swedbank sold out of Twist Bioscience (TWST) in Q3 2022, closing a stake of 60,200 shares — an estimated $2.1M sold.

Swedbank first reported a position in TWST in Q1 2021 and held it in 6 quarters. The position peaked at $12.1M in Q1 2021. 220 funds tracked by Wall St. Rank hold TWST as of Q3 2022.

  • Swedbank reported no remaining Twist Bioscience position as of Q3 2022 after selling out during the quarter.
  • Swedbank sold 60,200 Twist Bioscience shares in Q3 2022, an estimated $2.1M.
  • Swedbank first reported a position in Twist Bioscience in Q1 2021 and held it in 6 quarters.
  • Swedbank's Twist Bioscience position peaked at $12.1M in Q1 2021.
  • 220 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2022.

Based on Swedbank's 13F filing for Q3 2022, filed 6 Dec 2024.